Medtech Acquisition Corp Stock Short Ratio
| MTACUDelisted Stock | USD 9.86 0.00 0.00% |
Medtech Acquisition Corp fundamentals help investors to digest information that contributes to Medtech Acquisition's financial success or failures. It also enables traders to predict the movement of Medtech Stock. The fundamental analysis module provides a way to measure Medtech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtech Acquisition stock.
Medtech |
Medtech Acquisition Corp Company Short Ratio Analysis
Medtech Acquisition's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Medtech Acquisition Corp has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Capital Markets sector and about the same as Financials (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Medtech Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtech Acquisition's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtech Acquisition could also be used in its relative valuation, which is a method of valuing Medtech Acquisition by comparing valuation metrics of similar companies.Medtech Acquisition is currently under evaluation in short ratio category among its peers.
Medtech Fundamentals
| Return On Asset | -0.0193 | |||
| Current Valuation | 81.09 M | |||
| Price To Earning | 39.61 X | |||
| EBITDA | (8.58 M) | |||
| Net Income | 5.54 M | |||
| Cash And Equivalents | 69.18 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.74 M) | |||
| Earnings Per Share | 0.26 X | |||
| Beta | -0.0423 | |||
| Market Capitalization | 306.25 M | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
| Working Capital | (2.14 M) | |||
| Z Score | 75.01 | |||
| Net Asset | 20.19 M |
About Medtech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtech Acquisition Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtech Acquisition Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Medtech Stock
If you are still planning to invest in Medtech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medtech Acquisition's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |